Tag: Boston Therapeutics Inc
BXT-25 – CAN BIOXYTRAN INC’S NOVEL DRUG REVOLUTIONIZE OXYGEN DELIVERY?
Ponder this!
In the event of a brain stroke, the brain loses 32,000 neurons, 230 million synapses, 200 meters/220 yards of myelinated fibers and ages...
Companies In Focus In The Type 2 Diabetes Market
Diabetes is a silent killer which is slowly reaching endemic proportions in developed as well as developing countries. The rise in obesity, sedentary lifestyles,...
We are looking for talented interns to learn and help investors find valuable companies.